IRF7 and cardiac hypertrophy: Unlike in DM models, Irf7 gene expression showed no significant alterations after angiotensin II (AngII)-induced HF, and heart-specific overexpression of Irf7 significantly attenuated pressure overload–induced cardiac hypertrophy, fibrosis, and dysfunction [47].